A new FDA advisory panel meeting, influenced by RFK Jr.'s push for broader access, will weigh the potential benefits and risks of widely promoted peptides. Click the link in bio to read The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines WHAT ARE THE NEGATIVE SIDE EFFECTS OF PEPTIDE THERAPY IN CHARLESTON, SC? CHARLESTON HEALTHSPAN INSTITUTE